Nexgel (NXGL) Capital Leases (2024 - 2025)
Nexgel posted quarterly Capital Leases of $242000.0 for Q4 2025, down 21.17% year-on-year from $307000.0 in Q4 2024, and down 6.56% on a QoQ basis from $259000.0 in Q3 2025.
Nexgel (NXGL) has 2 years of Capital Leases data on file, last reported at $242000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Leases fell 21.17% year-over-year to $242000.0; the trailing twelve-month figure through Dec 2025 stood at $242000.0 (down 21.17% YoY), and the FY2025 full-year result was $242000.0, down 21.17% from the prior year.
- Capital Leases for Q4 2025 stood at $242000.0, down from $259000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $352000.0 in Q1 2024 and bottomed at $242000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nexgel | 31,199.58 | -1.34 Mn | 819,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 242,000.00 |
| Sep 30, 2025 | 259,000.00 |
| Jun 30, 2025 | 275,000.00 |
| Mar 31, 2025 | 293,000.00 |
| Dec 31, 2024 | 307,000.00 |
| Sep 30, 2024 | 323,000.00 |
| Jun 30, 2024 | 339,000.00 |
| Mar 31, 2024 | 352,000.00 |